Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons

[1]  S. Lal,et al.  Buspirone: a potential atypical neuroleptic. , 1983, Life sciences.

[2]  P. Wood,et al.  Striatal 3-methoxytyramine as an index of dopamine release: Effects of electrical stimulation , 1982, Neuroscience Letters.

[3]  P. Wood.  Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat. , 1982, The Journal of pharmacology and experimental therapeutics.

[4]  J. Coyle.  The clinical use of antipsychotic medications. , 1982, The Medical clinics of North America.

[5]  P. Wood.  A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionization. , 1982, Biomedical mass spectrometry.

[6]  C. Perego,et al.  Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytyramine , 1981, Neuroscience Letters.

[7]  T. Crowley,et al.  Motility, Parkinsonism, and prolactin with thiothixene and thioridazine. , 1981, Archives of general psychiatry.

[8]  R. Adams,et al.  Dopamine release in N. accumbens and striatum by clozapine: Simultaneous monitoring by in vivo electrochemistry , 1980, Neuropharmacology.

[9]  G. Rebec,et al.  “Classical” and “atypical” antipsychotic drugs: Differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens , 1979, Pharmacology Biochemistry and Behavior.

[10]  A. D. Di Giulio,et al.  3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC. , 1978, Life sciences.

[11]  J. Liebman,et al.  Differential behavioral effects of sulpiride in the rat and squirrel monkey. , 1978, European journal of pharmacology.

[12]  C. Mao,et al.  Turnover rates of γ-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. accumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics , 1978, Neuropharmacology.

[13]  J. Gerlach,et al.  CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIA , 1974, Acta psychiatrica Scandinavica.

[14]  D. Demaio.  Clozapine, a novel major tranquilizer. Clinical experiences and pharmacotherapeutic hypotheses. , 1972 .

[15]  R. T. Kelleher,et al.  Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys. , 1983, The Journal of pharmacology and experimental therapeutics.

[16]  M. Ackenheil,et al.  Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man. , 1974, Advances in biochemical psychopharmacology.